Search

Search Results

1. Novel target and treatment agents for natural killer/T-cell lymphoma

   The rapidly increasing use of high-throughput screening had produced a plethora of expanding knowledge on the molecular basis of natural...

   **ao-Peng Tian, Yi Cao, ... Qing-Qing Cai in Journal of Hematology & Oncology

   Article Open access 22 July 2023
   

2. Clinicopathological characteristics associated with the engraftment of patient lymphoma cells in NOG mice

   Patient-derived xenograft (PDX) mouse models are useful for deepening our understanding of the biology of malignant lymphoma; however, factors...

   Satomi Sahashi, Kazuyuki Shimada, ... Hitoshi Kiyoi in International Journal of Hematology

   Article 02 May 2023
   

3. First observation of intraocular extranodal natural killer/T-cell lymphoma secondary to a retroperitoneal tumour: a case report and comparative review

   Background

   Vitreoretinal lymphomas are difficult to diagnose due to their insidious onset and inaccessible focal points. Natural killer/T-cell derived...

   Binyao Chen, Shizhao Yang, Wenru Su in BMC Ophthalmology

   Article Open access 26 March 2022
   

4. Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study

   We conducted a phase II clinical trial to develop an autologous EBV-specific T cell product (baltaleucel T) for advanced, relapsed ENKTL. Among 47...

   Won Seog Kim, Yasuhiro Oki, ... Helen E. Heslop in Annals of Hematology

   Article 24 July 2021
   

5. Atezolizumab in combination with intrathecal chemotherapy and radiation for treatment of isolated cerebral nervous system relapse in a patient with extranodal NK/T cell lymphoma: a case report

   Background

   Extranodal NK/T cell lymphoma (ENKTL) is an aggressive form of Epstein-Barr virus (EBV)-associated non-Hodgkin’s lymphoma which...

   Amanda E. Lipsitt, Jaclyn Y. Hung, Anne-Marie Langevin in Journal of Medical Case Reports

   Article Open access 05 March 2021
   

6. Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report

   Introduction

   Extranodal, natural-killer/T-cell lymphoma of nasal type is a rare but aggressive disease usually presenting as progressive necrotic...

   Fatemeh Adabifirouzjaei, Bharam Khazai, ... Ghazaleh Shoja-e-Razavi in Journal of Medical Case Reports

   Article Open access 26 October 2021
   

7. Clinical-radiomic features predict survival in patients with extranodal nasal-type natural killer/T cell lymphoma

   Purpose

   To investigate the value of MRI-based radiomic features integrated with clinical indicators for survival prediction in patients with...

   **nyan Wang, **aoxia Qu, ... Junfang **an in Chinese Journal of Academic Radiology

   Article 26 August 2022
   

8. Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis

   Purpose

   Nasal type extranodal natural killer/T-cell lymphoma (ENKTL) can be associated with hemophagocytic lymphohistiocytosis (NK/T-LAHLH), which is...

   Liqiang Wei, Lei Yang, ... **gwen Wang in Journal of Cancer Research and Clinical Oncology

   Article 06 October 2020
   

9. Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study

   Background

   Natural killer/T-cell lymphoma (NKTCL) is a disease with limited treatment options and poor outcomes. Daratumumab monotherapy demonstrated...

   Huiqiang Huang, Jun Zhu, ... Won Seog Kim in Journal of Hematology & Oncology

   Article Open access 15 February 2021
   

10. Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphoma

    Intravascular large B-cell lymphoma (IVLBCL) is a rare aggressive extranodal non-Hodgkin lymphoma. The predominant, if not exclusive, growth of...

    Filippo Bagnoli, Giuditta Pini, ... Emilio Berti in Clinical and Experimental Medicine

    Article Open access 05 March 2024
    

11. Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives

    CD30 is overexpressed in several lymphoma types, including classic Hodgkin lymphoma (cHL), some peripheral T-cell lymphomas (PTCL), and some...

    H. Miles Prince, Martin Hutchings, ... Ranjana Advani in Annals of Hematology

    Article Open access 13 December 2022

12. PD-1 blockade in extranodal NK/T-cell lymphoma: who is in charge?

    Liang Wang, **g-wen Wang in Leukemia

    Article 02 October 2020

13. An Unusual Presentation of Midline Lethal Granuloma

    Extranodal natural killer T-cell lymphoma, nasal type (ENKTCL), is a rare form of non-Hodgkin lymphoma that is strongly related to Epstein-Barr Virus...

    Ein Wan Chin, Jeyasakthy Saniasiaya, ... Ngan Kah Wai in Indian Journal of Otolaryngology and Head & Neck Surgery

    Article 28 December 2023
    

14. Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging Directions

    Adult T-cell leukemia/lymphoma (ATL) is a rare, aggressive subtype of peripheral T-cell lymphoma develo** after many years of chronic, asymptomatic...

    Robert Stuver, Steven M. Horwitz, Zachary D. Epstein-Peterson in Current Treatment Options in Oncology

    Article 10 June 2023
    

15. Retrospective analysis of diagnosis and therapeutic strategies for patients with hepatosplenic T cell lymphoma

    Hepatosplenic T cell lymphoma (HSTCL) is a rare and aggressive lymphoma with no standard treatment and poor treatment response. From 2001–2021, 20...

    Youngkyung Jeon, Sang Eun Yoon, ... Won Seog Kim in Annals of Hematology

    Article 16 May 2023
    

16. PEG-Asparaginase Single-Agent Rescue in an Advanced Case of Monomorphic Epitheliotropic Intestinal T Cell Lymphoma

    Purpose

    MEITL is a very rare and highly aggressive peripheral T cell lymphoma with poor prognosis and for which there is no standard...

    Emiliano Barbieri, Stefano Pozzi, ... Giovanna Leonardi in Journal of Gastrointestinal Cancer

    Article 01 March 2022
    

17. Conjunctival Lymphoma

    Lymphoma of the conjunctiva is an ocular malignancy derived from clonal proliferation of lymphocytes. The majority of conjunctival lymphoma is...

    Lindsay A. McGrath, David A. Ryan, ... William J. Glasson in Eye

    Article Open access 26 July 2022
    

18. Epigenetic alterations and advancement of lymphoma treatment

    Lymphomas, complex and heterogeneous malignant tumors, originate from the lymphopoietic system. These tumors are notorious for their high recurrence...

    Shuhui Zhuang, Zhaobo Yang, ... Fengyuan Che in Annals of Hematology

    Article 15 August 2023
    

19. Causal relationships between circulating inflammatory cytokines and diffuse large B cell lymphoma: a bidirectional Mendelian randomization study

    Diffuse large B cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Studies indicated that inflammatory cytokines involved in the...

    Jieni Yu, Leihua Fu, ... Chao Xu in Clinical and Experimental Medicine

    Article 01 November 2023
    

20. Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study

    Immune evasion, due to abnormal expression of programmed-death ligands 1 and 2 (PD-L1/PD-L2), predicts poor outcomes with chemoimmunotherapy in...

    Kate Manos, Geoffrey Chong, ... Eliza A. Hawkes in Leukemia

    Article 11 March 2023